Nanoscale Defenses

Coating hospital surfaces, surgical equipment, patient implants, and water-delivery systems with nanoscale patterns and particles could curb the rise of hospital-acquired infections.

Written byEdward D. Marks and Steven Smith
| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00
Share

FROM TOP (LEFT TO RIGHT): © Science Source/CDC/Phanie; © Science Source/Gary D. Gaugler; © Science Source/Eye of Science; Mary Nora Dickson; © Science Source/David Scharf

Picture a hospital room: white walls, stainless steel IV poles and bedrails, scratchy bedsheets. For more than 100 years, this has been the standard hospital environment, and for most of that time, isolating patients in hygienic rooms, instead of en masse in group clinics or sanatoria, has helped curb the spread of infections that once killed nearly half of soldiers on the battlefield and more than a third of newborn infants. But with the recent rise in antibiotic-resistant pathogens, this standard is no longer sustainable. In 2011, the most recent year data are available from the US Centers for Disease Control and Prevention (CDC), some 720,000 patients acquired an infection while being treated in a health care facility; more than 75,000 of those people died.

“Imagine one full jumbo jet crashed each day, killing everyone on board,” says Michael Schmidt, vice chairman of microbiology and immunology at the Medical University of South Carolina (MUSC). “This is precisely the number of people that die each day in the U.S. from a hospital-associated infection.”

We can turn almost any material into one that reduces bacterial adhesion and growth, all by imple­menting nanoscale features.—Thomas Webster,
Northeastern Univer­sity

In the face of such hospital-acquired, or nosocomial, infections, and the impossibility of developing effective antibiotics quickly enough, researchers are looking to update that white-walled hospital room. The stainless steel IV ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies